ZURICH—Officials at Glaxo, the British pharmaceutical giant that has agreed to purchase the Geneva research laboratory of Biogen N.Y., have promised that the facility will retain a degree of autonomy ...

Biogen isn’t shy about aspirations to expand beyond neurology and further establish itself in immunology and rare diseases. Recent business development deals have focused on enhancing the company’s ...

Eleanor Nkera during her final internship poster presentation at Biogen. From the Boston Business Journal. Eleanor Nkera grew up in Medford, Massachusetts, a stone’s throw away from the life sciences ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three buildings to one In the first major deal at MIT’s ambitious overhaul of the old ...

Biogen said Wednesday it will acquire a California biotech that specializes in diseases of the immune system for $1.15 billion upfront as the Cambridge drugmaker seeks to bolster its pipeline of ...

Biogen says it’s pledging $250,000 to support a new life-sciences center in collaboration with Durham Technical Community College — funds the company hopes will expand the pool of workers qualified ...

(RTTNews) - Biogen Inc. (BIIB) announced Monday plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real estate consolidation plan in ...

One of the most prominent biotech companies is consolidating Cambridge operations with a full-building lease at a new Kendall Square development. A Rendering Of Biomed Realty And Mit Investment ...